(Institución)

Digital.CSIC > Biología y Biomedicina > Instituto de Investigaciones Biomédicas "Alberto Sols" (IIBM) > (IIBM) Artículos >

Compartir

EndNote

Impacto

Artículos relacionados

Registro de acceso cerrado Structural and functional characterization of Nrf2 degradation by the glycogen synthase kinase 3/β-TrCP axis

Autor :Rada, Patricia
Rojo, Ana I.
Innamorato, Nadia G.
Tobón-Velasco, Julio C.
García-Mayoral, M. F.
Hayes, John D.
Cuadrado, Antonio
Palabras clave :NF-E2-related factor 2, Nrf2, Redox homeostasis, GSK-3β
Fecha de publicación :30-sep-2012
Editor:American Society for Microbiology
Citación :Molecular and Cellular Biology 32(17): 3486-3499 (2012)
Resumen:The transcription factor NF-E2-related factor 2 (Nrf2) is a master regulator of a genetic program, termed the phase 2 response, that controls redox homeostasis and participates in multiple aspects of physiology and pathology. Nrf2 protein stability is regulated by two E3 ubiquitin ligase adaptors, Keap1 and β-TrCP, the latter of which was only recently reported. Here, two-dimensional (2D) gel electrophoresis and site-directed mutagenesis allowed us to identify two serines of Nrf2 that are phosphorylated by glycogen synthase kinase 3β (GSK-3β) in the sequence DSGISL. Nuclear magnetic resonance studies defined key residues of this phosphosequence involved in docking to the WD40 propeller of β-TrCP, through electrostatic and hydrophobic interactions. We also identified three arginine residues of β-TrCP that participate in Nrf2 docking. Intraperitoneal injection of the GSK-3 inhibitor SB216763 led to increased Nrf2 and heme oxygenase-1 levels in liver and hippocampus. Moreover, mice with hippocampal absence of GSK-3β exhibited increased levels of Nrf2 and phase 2 gene products, reduced glutathione, and decreased levels of carbonylated proteins and malondialdehyde. This study establishes the structural parameters of the interaction of Nrf2 with the GSK-3/β-TrCP axis and its functional relevance in the regulation of Nrf2 by the signaling pathways that impinge on GSK-3.
Versión del editor:http://dx.doi.org/10.1128/​MCB.00180-12
URI :http://hdl.handle.net/10261/57984
ISSN:0270-7306
E-ISSN:1098-5549
DOI:10.1128/​MCB.00180-12
Aparece en las colecciones: (IIBM) Artículos
(IQFR) Artículos

NOTA: Los ítems de Digital.CSIC están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.